Search Results - Matthew During
- Showing 1 - 2 results of 2
-
1
Adipose tissue insulin receptor knockdown via a new primate-derived hybrid recombinant AAV serotype by Xianglan Liu, Daniel Magee, Chuansong Wang, Travis McMurphy, Andrew Slater, Matthew During, Lei Cao
Published in Molecular Therapy: Methods & Clinical Development (2014-01-01)Get full text
Article -
2
Cholesterol 24-hydroxylase is a novel pharmacological target for anti-ictogenic and disease modification effects in epilepsy by Alessia Salamone, Gaetano Terrone, Rossella Di Sapia, Silvia Balosso, Teresa Ravizza, Luca Beltrame, Ilaria Craparotta, Laura Mannarino, Sara Raimondi Cominesi, Massimo Rizzi, Alberto Pauletti, Sergio Marchini, Luca Porcu, Till S. Zimmer, Eleonora Aronica, Matthew During, Brett Abrahams, Shinichi Kondo, Toshiya Nishi, Annamaria Vezzani
Published in Neurobiology of Disease (2022-10-01)Get full text
Article